1171 related articles for article (PubMed ID: 34093845)
1. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
Liu B; Le KX; Park MA; Wang S; Belanger AP; Dubey S; Frost JL; Holton P; Reiser V; Jones PA; Trigg W; Di Carli MF; Lemere CA
J Neurosci; 2015 Nov; 35(47):15716-30. PubMed ID: 26609163
[TBL] [Abstract][Full Text] [Related]
3. A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss.
Cohen RM; Rezai-Zadeh K; Weitz TM; Rentsendorj A; Gate D; Spivak I; Bholat Y; Vasilevko V; Glabe CG; Breunig JJ; Rakic P; Davtyan H; Agadjanyan MG; Kepe V; Barrio JR; Bannykh S; Szekely CA; Pechnick RN; Town T
J Neurosci; 2013 Apr; 33(15):6245-56. PubMed ID: 23575824
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
[TBL] [Abstract][Full Text] [Related]
5. Spatio-temporal metabolic rewiring in the brain of TgF344-AD rat model of Alzheimer's disease.
Muñoz-Moreno E; Simões RV; Tudela R; López-Gil X; Soria G
Sci Rep; 2022 Oct; 12(1):16958. PubMed ID: 36216838
[TBL] [Abstract][Full Text] [Related]
6. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
[TBL] [Abstract][Full Text] [Related]
7. Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models.
Brendel M; Jaworska A; Probst F; Overhoff F; Korzhova V; Lindner S; Carlsen J; Bartenstein P; Harada R; Kudo Y; Haass C; Van Leuven F; Okamura N; Herms J; Rominger A
J Nucl Med; 2016 May; 57(5):792-8. PubMed ID: 26912432
[TBL] [Abstract][Full Text] [Related]
8. Altered basal forebrain function during whole-brain network activity at pre- and early-plaque stages of Alzheimer's disease in TgF344-AD rats.
van den Berg M; Adhikari MH; Verschuuren M; Pintelon I; Vasilkovska T; Van Audekerke J; Missault S; Heymans L; Ponsaerts P; De Vos WH; Van der Linden A; Keliris GA; Verhoye M
Alzheimers Res Ther; 2022 Oct; 14(1):148. PubMed ID: 36217211
[TBL] [Abstract][Full Text] [Related]
9. Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease.
Goodman AM; Langner BM; Jackson N; Alex C; McMahon LL
J Neurosci; 2021 Jun; 41(26):5747-5761. PubMed ID: 33952633
[TBL] [Abstract][Full Text] [Related]
10. In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders.
Maeda J; Zhang MR; Okauchi T; Ji B; Ono M; Hattori S; Kumata K; Iwata N; Saido TC; Trojanowski JQ; Lee VM; Staufenbiel M; Tomiyama T; Mori H; Fukumura T; Suhara T; Higuchi M
J Neurosci; 2011 Mar; 31(12):4720-30. PubMed ID: 21430171
[TBL] [Abstract][Full Text] [Related]
11. Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice.
Ilievski V; Zuchowska PK; Green SJ; Toth PT; Ragozzino ME; Le K; Aljewari HW; O'Brien-Simpson NM; Reynolds EC; Watanabe K
PLoS One; 2018; 13(10):e0204941. PubMed ID: 30281647
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal multimodal in vivo molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss.
Chiquita S; Ribeiro M; Castelhano J; Oliveira F; Sereno J; Batista M; Abrunhosa A; Rodrigues-Neves AC; Carecho R; Baptista F; Gomes C; Moreira PI; Ambrósio AF; Castelo-Branco M
Hum Mol Genet; 2019 Jul; 28(13):2174-2188. PubMed ID: 30816415
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography.
Rejc L; Gómez-Vallejo V; Joya A; Arsequell G; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Iglesias L; Capetillo-Zarate E; Ramos-Cabrer P; Martin A; Llop J
Alzheimers Res Ther; 2022 Jun; 14(1):80. PubMed ID: 35676734
[TBL] [Abstract][Full Text] [Related]
14. Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer's disease.
Morrone CD; Lai AY; Bishay J; Hill ME; McLaurin J
Transl Neurodegener; 2022 May; 11(1):26. PubMed ID: 35501886
[TBL] [Abstract][Full Text] [Related]
15. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ;
Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897
[TBL] [Abstract][Full Text] [Related]
16. [
Ballweg A; Klaus C; Vogler L; Katzdobler S; Wind K; Zatcepin A; Ziegler SI; Secgin B; Eckenweber F; Bohr B; Bernhardt A; Fietzek U; Rauchmann BS; Stoecklein S; Quach S; Beyer L; Scheifele M; Simmet M; Joseph E; Lindner S; Berg I; Koglin N; Mueller A; Stephens AW; Bartenstein P; Tonn JC; Albert NL; Kümpfel T; Kerschensteiner M; Perneczky R; Levin J; Paeger L; Herms J; Brendel M
J Neuroinflammation; 2023 Mar; 20(1):68. PubMed ID: 36906584
[TBL] [Abstract][Full Text] [Related]
17. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
[TBL] [Abstract][Full Text] [Related]
19. [
Sanabria Bohórquez S; Marik J; Ogasawara A; Tinianow JN; Gill HS; Barret O; Tamagnan G; Alagille D; Ayalon G; Manser P; Bengtsson T; Ward M; Williams SP; Kerchner GA; Seibyl JP; Marek K; Weimer RM
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2077-2089. PubMed ID: 31254035
[TBL] [Abstract][Full Text] [Related]
20. Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-β attenuation.
Morrone CD; Bazzigaluppi P; Beckett TL; Hill ME; Koletar MM; Stefanovic B; McLaurin J
Brain; 2020 Jan; 143(1):359-373. PubMed ID: 31782760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]